Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, February 02, 2018
TransPerfect Life Sciences announced that ARCA Biopharma has selected TransPerfect’s Trial Interactive eTMF solution as their enterprise platform for clinical trials.
read more
ARCA biopharma announced that Medtronic has extended the U.S., Canadian and European Clinical Trial Collaboration Agreement with ARCA for an additional year to April 2019.
read more
Arch Biopartners Inc. announced that three additional clinical sites in Turkey have joined the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI).
read more
Arch Biopartners engaged a global CRO to initiate and conduct a Phase II trial in the U.S. for its lead drug Metablok for COVID-19 complications.
read more
Arch Biopartners has hired Dalton Pharma Services to perform the good manufacturing practice campaign for Metablok, the company's drug candidate for preventing acute kidney injury.
read more
ArcherDX announced a strategic collaboration with AstraZeneca to develop assays to support multiple planned Phase 3 clinical trials for AstraZeneca's targeted immuno-oncology therapeutics.
read more
ArcherDX is entering into a collaboration with Bristol Myers to utilize PCM assays to understand the potential benefits of MRD detection in cancer patients treated with immunotherapy.
read more
Archimica has started the operation of its expanded development laboratories at its Lodi (Italy) site. This recent $1.6 Million investment has more than doubled the company's capabilities to realize API and GMP Building Block custom process ...
read more
Archimica has started the operation of its expanded multi-purpose manufacturing capacity at its Lodi (Italy) site. Recent investment has added significantly to the company´s capabilities overall 170 m3 highly flexible reactor capacity to realize API ...
read more
Thursday, August 07, 2025
Arcinova, a Quotient Sciences company, and UK-based Contract Research Development and Manufacturing Organization (CRDMO), announced the appointment of Dr. Christian Dowdeswell as new Managing Director.
read more
Wednesday, April 18, 2018
Arcinova has announced the award of a £1.5 million Innovate UK grant for the development of new flexible modular manufacturing technologies.
read more
Monday, February 10, 2020
Through its fully automated drug discovery platform, Arctoris enables researchers and biotechnological entrepreneurs to design and remotely execute advanced cell-based, molecular biology and biochemical assays.
read more
Wednesday, November 13, 2019
Arctoris announced the appointment of Professor John Mattick AO FAA FTSE FAHMS FRSN HonFRCPA GAICD as a Member of the Board of Directors, and Daniel Thomas PhD LCGI as Head of Discovery Biology.
read more
Arctoris has established a broad range of remotely accessible COVID-19 assays.
read more
Wednesday, December 11, 2019
Arctoris has opened its new global headquarters and state-of-the-art R&D facility in Oxford, UK.
read more